UHS Stock Forecast & Price Target

Universal Health Services is attractive because its behavioral health franchise continues to grow, with S-f revenue up 4.0% y/y, pricing up 2.1%, and adj patient days up 2.1%, while higher-margin behavioral operations generate over 55% of pretax profits despite acute care producing over 55% of revenue. The company also showed improving cost discipline, as S-f SW&B per adj patient day rose 3.6% y/y but headcount growth slowed to about 1.5%, supporting a stronger operating base even after a tough 3Q26 EBITDA result. Management’s investments in de novo expansion, outpatient integration through TALK, and easing comps create a credible path to margin expansion and better execution against 2026 and 2027 headwinds.

Universal Health Services is facing a softer near-term earnings profile as 2026 guidance now points to the low end of the $2.610B–$2.717B Adj. EBITDA-NCI range, with a $85M HIX headwind, a $35M California staffing drag, and an $80M-$100M EBITDA loss tied to Cedar Hill, the new FL facility, and Laurel Ridge decertification. Acute care is under pressure from a 0.7% decline in surgeries and an accelerating shift to ASCs and physician offices, while HIX volume fell 17% y/y and pricing declined 1.7% y/y, showing that reimbursement and utilization trends are eroding operating leverage. Although behavioral health remains the higher-margin profit engine, the company’s concentration in Nevada, Texas, and California, plus the UK exposure and regulatory and labor risks, leaves it vulnerable to margin compression and weaker capital flexibility.